Cited 0 times in
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.